270 related articles for article (PubMed ID: 30333494)
1. Targeting SPINK1 in the damaged tumour microenvironment alleviates therapeutic resistance.
Chen F; Long Q; Fu D; Zhu D; Ji Y; Han L; Zhang B; Xu Q; Liu B; Li Y; Wu S; Yang C; Qian M; Xu J; Liu S; Cao L; Chin YE; Lam EW; Coppé JP; Sun Y
Nat Commun; 2018 Oct; 9(1):4315. PubMed ID: 30333494
[TBL] [Abstract][Full Text] [Related]
2. Targeting epiregulin in the treatment-damaged tumor microenvironment restrains therapeutic resistance.
Wang C; Long Q; Fu Q; Xu Q; Fu D; Li Y; Gao L; Guo J; Zhang X; Lam EW; Campisi J; Sun Y
Oncogene; 2022 Nov; 41(45):4941-4959. PubMed ID: 36202915
[TBL] [Abstract][Full Text] [Related]
3. Serine Protease Inhibitor Kazal Type 1, A Potential Biomarker for the Early Detection, Targeting, and Prediction of Response to Immune Checkpoint Blockade Therapies in Hepatocellular Carcinoma.
Jia J; Ga L; Liu Y; Yang Z; Wang Y; Guo X; Ma R; Liu R; Li T; Tang Z; Wang J
Front Immunol; 2022; 13():923031. PubMed ID: 35924241
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 increases expression of serine protease inhibitor Kazal type 1 through STAT3 in colorectal adenocarcinoma.
Räsänen K; Lehtinen E; Nokelainen K; Kuopio T; Hautala L; Itkonen O; Stenman UH; Koistinen H
Mol Carcinog; 2016 Dec; 55(12):2010-2023. PubMed ID: 26663388
[TBL] [Abstract][Full Text] [Related]
5. Functional Roles of SPINK1 in Cancers.
Lin TC
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33916984
[TBL] [Abstract][Full Text] [Related]
6. SPINK1 as a plasma marker for tumor hypoxia and a therapeutic target for radiosensitization.
Suwa T; Kobayashi M; Shirai Y; Nam JM; Tabuchi Y; Takeda N; Akamatsu S; Ogawa O; Mizowaki T; Hammond EM; Harada H
JCI Insight; 2021 Nov; 6(21):. PubMed ID: 34747365
[TBL] [Abstract][Full Text] [Related]
7. Identification and Exploration of Serine Peptidase Inhibitor Kazal Type I (SPINK1) as a Potential Biomarker Correlated with the Progression of Non-Small Cell Lung Cancer.
Li D; Zhang X; Ding Z; Ai R; Shi L; Wang Z; He Q; Dong Y; Zhu Y; Ouyang W; He Y
Cell Biochem Biophys; 2022 Dec; 80(4):807-818. PubMed ID: 36194314
[TBL] [Abstract][Full Text] [Related]
8. SFRP2 augments WNT16B signaling to promote therapeutic resistance in the damaged tumor microenvironment.
Sun Y; Zhu D; Chen F; Qian M; Wei H; Chen W; Xu J
Oncogene; 2016 Aug; 35(33):4321-34. PubMed ID: 26751775
[TBL] [Abstract][Full Text] [Related]
9. MAPK inhibitors induce serine peptidase inhibitor Kazal type 1 (SPINK1) secretion in BRAF V600E-mutant colorectal adenocarcinoma.
Räsänen K; Dang KX; Mustonen H; Ho TH; Lintula S; Koistinen H; Stenman UH; Haglund C; Stenman J
Mol Oncol; 2018 Feb; 12(2):224-238. PubMed ID: 29193645
[TBL] [Abstract][Full Text] [Related]
10. Targeting an autocrine IL-6-SPINK1 signaling axis to suppress metastatic spread in ovarian clear cell carcinoma.
Mehner C; Miller E; Hockla A; Coban M; Weroha SJ; Radisky DC; Radisky ES
Oncogene; 2020 Oct; 39(42):6606-6618. PubMed ID: 32929152
[TBL] [Abstract][Full Text] [Related]
11. Targeting amphiregulin (AREG) derived from senescent stromal cells diminishes cancer resistance and averts programmed cell death 1 ligand (PD-L1)-mediated immunosuppression.
Xu Q; Long Q; Zhu D; Fu D; Zhang B; Han L; Qian M; Guo J; Xu J; Cao L; Chin YE; Coppé JP; Lam EW; Campisi J; Sun Y
Aging Cell; 2019 Dec; 18(6):e13027. PubMed ID: 31493351
[TBL] [Abstract][Full Text] [Related]
12. miR-421 up-regulation by the oleanolic acid derivative K73-03 regulates epigenetically SPINK1 transcription in pancreatic cancer cells leading to metabolic changes and enhanced apoptosis.
Shopit A; Li X; Tang Z; Awsh M; Shobet L; Niu M; Wang H; Mousa H; Alshwmi M; Tesfaldet T; Gamallat Y; Li H; Chu P; Ahmad N; Jamalat Y; Ai J; Qaed E; Almoiliqy M; Wang S; Tang Z
Pharmacol Res; 2020 Nov; 161():105130. PubMed ID: 32818653
[TBL] [Abstract][Full Text] [Related]
13. Serine protease inhibitor Kazal type 1 (SPINK1) promotes proliferation, migration, invasion and radiation resistance in rectal cancer patients receiving concurrent chemoradiotherapy: a potential target for precision medicine.
Chen YT; Tseng TT; Tsai HP; Kuo SH; Huang MY; Wang JY; Chai CY
Hum Cell; 2022 Nov; 35(6):1912-1927. PubMed ID: 36053457
[TBL] [Abstract][Full Text] [Related]
14. SPINK1 Overexpression Correlates with Hepatocellular Carcinoma Treatment Resistance Revealed by Single Cell RNA-Sequencing and Spatial Transcriptomics.
Yang C; Guo L; Du J; Zhang Q; Zhang L
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540686
[TBL] [Abstract][Full Text] [Related]
15. SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma.
Man KF; Zhou L; Yu H; Lam KH; Cheng W; Yu J; Lee TK; Yun JP; Guan XY; Liu M; Ma S
Nat Commun; 2023 Nov; 14(1):7863. PubMed ID: 38030644
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B Virus X Protein-Induced Serine Protease Inhibitor Kazal Type 1 Is Associated with the Progression of HBV-Related Diseases.
Zhu C; Han H; Li J; Xu L; Liu F; Wu K; Liu X
Biomed Res Int; 2019; 2019():9321494. PubMed ID: 31240230
[TBL] [Abstract][Full Text] [Related]
17. Roles of serine protease inhibitor Kazal type 1 (SPINK1) in pancreatic diseases.
Ohmuraya M; Yamamura K
Exp Anim; 2011; 60(5):433-44. PubMed ID: 22041280
[TBL] [Abstract][Full Text] [Related]
18. SPINK1 promotes cell growth and metastasis of lung adenocarcinoma and acts as a novel prognostic biomarker.
Xu L; Lu C; Huang Y; Zhou J; Wang X; Liu C; Chen J; Le H
BMB Rep; 2018 Dec; 51(12):648-653. PubMed ID: 30545439
[TBL] [Abstract][Full Text] [Related]
19. DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-FGFR2 signaling.
Yu S; Ye J; Wang Y; Lu T; Liu Y; Liu N; Zhang J; Lu F; Ma D; Gale RP; Ji C
J Biol Chem; 2023 Jan; 299(1):102787. PubMed ID: 36509141
[TBL] [Abstract][Full Text] [Related]
20.
Zhang JW; Zhang D; Yin HS; Zhang H; Hong KQ; Yuan JP; Yu BP
Gut Microbes; 2023; 15(1):2197836. PubMed ID: 37017266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
